Steven Feldman to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Steven Feldman has written about Dose-Response Relationship, Drug.
Connection Strength
1.145
-
Haidari W, Bruinsma R, Cardenas-de la Garza JA, Feldman SR. Sarecycline Review. Ann Pharmacother. 2020 02; 54(2):164-170.
Score: 0.149
-
Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.
Score: 0.140
-
Feldman SR, Zhao Y, Zhou H, Herrera V, Tian H, Li Y. Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis. J Manag Care Spec Pharm. 2017 May; 23(5):583-589.
Score: 0.127
-
Feldman SR, Zhao Y, Navaratnam P, Friedman HS, Lu J, Tran MH. Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis. J Manag Care Spec Pharm. 2015 Mar; 21(3):201-9.
Score: 0.109
-
Davis SA, Krowchuk DP, Feldman SR. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States. South Med J. 2014 May; 107(5):292-3.
Score: 0.103
-
Sagransky M, Yentzer BA, Feldman SR. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009 Oct; 10(15):2555-62.
Score: 0.075
-
Fakhouri T, Yentzer BA, Feldman SR. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J Drugs Dermatol. 2009 Jul; 8(7):657-61.
Score: 0.074
-
Yelverton CB, Yentzer BA, Clark A, Pearce DJ, Balkrishnan R, Camacho FT, Boles A, Fleischer AB, Feldman SR. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis. Arch Dermatol. 2008 Sep; 144(9):1224-5.
Score: 0.070
-
Krejci-Manwaring J, McCarty MA, Camacho F, Manuel J, Hartle J, Fleischer A, Feldman SR. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol. 2008 Jul; 7(7):643-6.
Score: 0.069
-
Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol. 2008 Jan; 58(1):125-35.
Score: 0.066
-
Balkrishnan R, Camacho FT, Pearce DJ, Kulkarni AS, Spencer L, Fleischer AB, Feldman SR. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data. J Drugs Dermatol. 2005 Nov-Dec; 4(6):699-706.
Score: 0.057
-
Papp KA, Bissonnette R, Gooderham M, Feldman SR, Iversen L, Soung J, Draelos Z, Mamolo C, Purohit V, Wang C, Ports WC. Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. BMC Dermatol. 2016 10 03; 16(1):15.
Score: 0.030
-
Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L, Tatulych S. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. J Am Acad Dermatol. 2016 May; 74(5):841-50.
Score: 0.029
-
Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol. 2010 Sep; 63(3):457-65.
Score: 0.020
-
Stanfield JW, Feldman SR, Levitt J. Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens. J Drugs Dermatol. 2006 Apr; 5(4):321-4.
Score: 0.015
-
Housman TS, Norton AB, Feldman SR, Fleischer AB, Simpson EL, Hanifin JM, Antaya RJ. Tacrolimus ointment: utilization patterns in children under age 2 years. Dermatol Online J. 2004 Jul 15; 10(1):2.
Score: 0.013